These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19633445)

  • 1. Melatonin prevents fibrosis but not hypertrophy development in the left ventricle of NG-nitro-L-arginine-methyl ester hypertensive rats.
    Paulis L; Pechanova O; Zicha J; Krajcirovicova K; Barta A; Pelouch V; Adamcova M; Simko F
    J Hypertens Suppl; 2009 Aug; 27(6):S11-6. PubMed ID: 19633445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-arginine fails to protect against myocardial remodelling in L-NAME-induced hypertension.
    Simko F; Luptak I; Matuskova J; Krajcirovicova K; Sumbalova Z; Kucharska J; Gvozdjakova A; Simko J; Babal P; Pechanova O; Bernatova I
    Eur J Clin Invest; 2005 Jun; 35(6):362-8. PubMed ID: 15948896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats.
    Simko F; Pechanova O; Pelouch V; Krajcirovicova K; Mullerova M; Bednarova K; Adamcova M; Paulis L
    J Hypertens Suppl; 2009 Aug; 27(6):S5-10. PubMed ID: 19633453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of left ventricular hypertrophy and aortic remodelling in NO-deficient hypertensive rats: effect of L-arginine and spironolactone.
    Paulis L; Matuskova J; Adamcova M; Pelouch V; Simko J; Krajcirovicova K; Potacova A; Hulin I; Janega P; Pechanova O; Simko F
    Acta Physiol (Oxf); 2008 Sep; 194(1):45-55. PubMed ID: 18419778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin interactions with blood pressure and vascular function during L-NAME-induced hypertension.
    Paulis L; Pechanova O; Zicha J; Barta A; Gardlik R; Celec P; Kunes J; Simko F
    J Pineal Res; 2010 Mar; 48(2):102-8. PubMed ID: 20041987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regression of chronic L -NAME-treatment-induced left ventricular hypertrophy: effect of captopril.
    Bernátová I; Pechánová O; Pelouch V; Simko F
    J Mol Cell Cardiol; 2000 Feb; 32(2):177-85. PubMed ID: 10722795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of N-acetylcysteine and melatonin in adult spontaneously hypertensive rats with established hypertension.
    Pechánová O; Zicha J; Paulis L; Zenebe W; Dobesová Z; Kojsová S; Jendeková L; Sládková M; Dovinová I; Simko F; Kunes J
    Eur J Pharmacol; 2007 Apr; 561(1-3):129-36. PubMed ID: 17321519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic low-dose L-NAME treatment effect on cardiovascular system of borderline hypertensive rats: feedback regulation?
    Kopincova J; Puzserova A; Bernatova I
    Neuro Endocrinol Lett; 2008 Oct; 29(5):784-9. PubMed ID: 18987608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic N-acetylcysteine administration prevents development of hypertension in N(omega)-nitro-L-arginine methyl ester-treated rats: the role of reactive oxygen species.
    Rauchová H; Pechánová O; Kunes J; Vokurková M; Dobesová Z; Zicha J
    Hypertens Res; 2005 May; 28(5):475-82. PubMed ID: 16156512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart remodeling in the hereditary hypertriglyceridemic rat: effect of captopril and nitric oxide deficiency.
    Simko F; Luptak I; Matuskova J; Babal P; Pechanova O; Bernatova I; Hulin I
    Ann N Y Acad Sci; 2002 Jun; 967():454-62. PubMed ID: 12079874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactacystin-Induced Model of Hypertension in Rats: Effects of Melatonin and Captopril.
    Simko F; Pechanova O; Repova K; Aziriova S; Krajcirovicova K; Celec P; Tothova L; Vrankova S; Balazova L; Zorad S; Adamcova M
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein remodelling of the heart in NO-deficient hypertension: the effect of captopril.
    Pechánová O; Bernátová I; Pelouch V; Simko F
    J Mol Cell Cardiol; 1997 Dec; 29(12):3365-74. PubMed ID: 9441842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ivabradine, captopril and melatonin on the behaviour of rats in L-nitro-arginine methyl ester-induced hypertension.
    Aziriova S; Repova K; Krajcirovicova K; Baka T; Zorad S; Mojto V; Slavkovsky P; Hodosy J; Adamcova M; Paulis L; Simko F
    J Physiol Pharmacol; 2016 Dec; 67(6):895-902. PubMed ID: 28195070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertensive response to chronic NG-nitro-L-arginine methyl ester (L-NAME) treatment is similar in immature and adult Wistar rats.
    Zicha J; Pechánová O; Dobesová Z; Kunes J
    Clin Sci (Lond); 2003 Oct; 105(4):483-9. PubMed ID: 12816535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-NAME-induced protein remodeling and fibrosis in the rat heart.
    Pechánová O; Bernátová I; Pelouch V; Babál P
    Physiol Res; 1999; 48(5):353-62. PubMed ID: 10625224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antagonism of aldosterone receptor prevents the development of hypertensive heart failure induced by chronic inhibition of nitric oxide synthesis in rats.
    Tsukamoto O; Minamino T; Sanada S; Okada K; Hirata A; Fujita M; Shintani Y; Yulin L; Asano Y; Takashima S; Yamasaki S; Tomoike H; Hori M; Kitakaze M
    Cardiovasc Drugs Ther; 2006 Apr; 20(2):93-102. PubMed ID: 16761190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal melatonin or N-acetylcysteine therapy regulates hydrogen sulfide-generating pathway and renal transcriptome to prevent prenatal N
    Tain YL; Lee CT; Chan JY; Hsu CN
    Am J Obstet Gynecol; 2016 Nov; 215(5):636.e1-636.e72. PubMed ID: 27457113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valsartan improves L-NAME-exacerbated cardiac fibrosis with TGF-ß inhibition and apoptosis induction in spontaneously hypertensive rats.
    Akashiba A; Ono H; Ono Y; Ishimitsu T; Matsuoka H
    J Cardiol; 2008 Dec; 52(3):239-46. PubMed ID: 19027602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renoprotective effects of melatonin in young spontaneously hypertensive rats with L-NAME.
    Cheng MC; Wu TH; Huang LT; Tain YL
    Pediatr Neonatol; 2014 Jun; 55(3):189-95. PubMed ID: 24268813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin improves the restoration of endothelium-derived constricting factor signalling and inner diameter in the rat femoral artery after cessation of L-NAME treatment.
    Paulis L; Pechanova O; Zicha J; Liskova S; Celec P; Mullerova M; Kollar J; Behuliak M; Kunes J; Adamcova M; Simko F
    J Hypertens; 2010 Sep; 28 Suppl 1():S19-24. PubMed ID: 20823712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.